期刊
JOURNAL OF MEDICAL VIROLOGY
卷 95, 期 3, 页码 -出版社
WILEY
DOI: 10.1002/jmv.28582
关键词
children; COVID-19; immune escape; live-virus neutralization; omicron variant; SARS-CoV-2; vaccination
类别
Data on cross-neutralization of the SARS-CoV-2 omicron variant more than 1 year after infection show that previous wild-type infection does not provide sufficient immunity against the omicron variant. Only a small percentage of unvaccinated individuals, including children and adolescents, had neutralizing activity against omicron, indicating the urgency of vaccination strategies. mRNA vaccination in convalescent adults significantly increased neutralization against both delta and omicron variants, but the neutralization of omicron was still lower than that of delta.
Data on cross-neutralization of the SARS-CoV-2 omicron variant more than 1 year after SARS-CoV-2 infection are urgently needed, especially in children, to predict the likelihood of reinfection and to guide vaccination strategies. In a prospective observational cohort study, we evaluated live-virus neutralization of the SARS-CoV-2 omicron (BA.1) variant in children compared with adults 14 months after mild or asymptomatic wild-type SARS-CoV-2 infection. We also evaluated immunity to reinfection conferred by previous infection plus COVID-19 mRNA vaccination. We studied 36 adults and 34 children 14 months after acute SARS-CoV-2 infection. While 94% of unvaccinated adults (16/17) and children (32/34) neutralized the delta (B.1.617.2) variant, only 1/17 (5.9%) unvaccinated adults, 0/16 (0%) adolescents and 5/18 (27.8%) children <12 years of age had neutralizing activity against omicron (BA.1). In convalescent adults, one or two doses of mRNA vaccine increased delta and omicron neutralization 32-fold, similar to a third mRNA vaccination in uninfected adults. Neutralization of omicron was 8-fold lower than that of delta in both groups. In conclusion, our data indicate that humoral immunity induced by previous SARS-CoV-2 wild-type infection more than 1 year ago is insufficient to neutralize the current immune escape omicron variant.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据